MTSR (metsera.com) Rasio Nilai Pasar marang Nilai Buku

Simbol resmi perusahaan Metsera, Inc. (MTSR)

The market valuation chart for Metsera Inc (MTSR) illustrates the ambitions of the biotech startup Metsera Inc, which is attracting leading peptide specialists through generous venture capital and stock options. The current figure stands at 22.04. The business is currently focused on its own clinical trials for weight-loss treatments with no plans for mergers. Meanwhile, financial stability remains absent, as funds are being spent on research prior to obtaining regulatory approvals.

MTSR Metsera Therapeutics: Nilai Pasar marang Nilai Buku ing interval 01.02.2025 - 29.11.2025

Rincian metrik keuangan lan pasar Metsera, Inc. (MTSR)

- rega lan prakiraan konsensus rega:
Bagan rega Metsera Inc|MTSR - Konsensus nilai wajar
- data kapitalisasi pasar:
Nilai pasar Metsera Corp|MTSR - Nilai Wutuh Bisnis
- data kapitalisasi buku:
Nilai Buku saben Saham Metsera|MTSR - Nilai Akuntansi Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku metsera.com|MTSR - Total Aset Perusahaan
- data utang lan likuiditas:
Utang marang Ekuitas Metsera Inc|MTSR - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Metsera Corp|MTSR - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Metsera Corp
Analisis wiwitan perusahaan:Metsera Inc - MTSR
Produk asli Metsera Corp

This indicator measures the proportion between the business's market value and its net assets, determining the extent to which investors are overpaying for fundamental capital. For Metsera Inc (MTSR), whose value is based on venture optimism and ambitions in obesity therapy, the ratio of current market capitalization to its balance sheet reflects the level of market confidence in the company's future clinical successes.

Pesaing utama

Rasio Nilai Pasar marang Nilai Buku Ascendis Pharma A/S ASND|MDGL (madrigalpharma.com) - Nilai Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Corcept Therapeutics Incorporated CORT|Kapitalisasi Pasar marang Aset Bersih Rhythm Pharma|Akero Therapeutics Inc (AKRO) - Rasio Kapitalisasi Pasar marang Nilai Buku|Nilai Pasar marang Nilai Buku MoonLake Corp (MLTX)|Rasio Kapitalisasi Pasar marang Nilai Buku CRNX (Crinetics Pharmaceuticals)|newamsterdampharma.com - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Soleno Therapeutics, Inc. (SLNO)|FOLD: Nilai Pasar marang Nilai Buku|ETNB (89bio Corp) - Rasio Nilai Pasar marang Nilai Buku|Agios Corp (AGIO) - Rasio Kapitalisasi marang Aset Bersih|GPCR (Structure Therapeutics) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku mimedx.com (MDXG)|Rezolute (RZLT) - Rasio Kapitalisasi marang Aset Bersih|Nilai Pasar marang Nilai Buku LXRX (Lexicon Pharmaceuticals Inc)|MBX Bio - Rasio Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi marang Aset Bersih Altimmune Pharma ALT|AARD (Aardvark Therapeutics Inc) - Rasio Kapitalisasi Pasar marang Nilai Buku|sagimet.com (SGMT) - Koefisien Nilai Pasar marang Nilai Buku|BIOA - Rasio Kapitalisasi marang Aset Bersih|Biomea Fusion Inc (BMEA) - Multiplikator Kapitalisasi Pasar marang Nilai Buku|QNCX (Quince Therapeutics Inc) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku Fractyl Health, Inc|Rasio Kapitalisasi Pasar marang Nilai Buku vTv Therapeutics Inc. (VTVT)|Rasio Nilai Pasar marang Nilai Buku ATPC (agapeatpgroup.com)|PLUR: Rasio Nilai Pasar marang Nilai Buku|Synlogic Inc. - Koefisien Nilai Pasar marang Nilai Buku|LPCN - Rasio Nilai Pasar marang Nilai Buku|MTNB - Rasio Nilai Pasar marang Nilai Buku|Spruce Biosciences - Rasio Kapitalisasi Pasar marang Nilai Buku|GLTO (galecto.com) - Kapitalisasi Pasar marang Nilai Buku|CTCX: Rasio Nilai Pasar marang Nilai Buku|Kapitalisasi Pasar marang Nilai Buku LUMO|Rasio Nilai Pasar marang Nilai Buku ONVO (Organovo Holdings Inc)|Rasio Kapitalisasi marang Aset Bersih RDUS (Radius Pharmaceuticals)